Specific inhibition of macrophage CD40 might act as a “double-edged sword” by inhibiting atherosclerosis and stimulating arteriogenesis, resulting in a reduced ischemic burden without interfering in adaptive immunity. This evidence concerns the gene CD40 and atherosclerosis.